{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:25:19Z","timestamp":1758479119907},"reference-count":26,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T00:00:00Z","timestamp":1399507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T00:00:00Z","timestamp":1399507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Bayer Healthcare Company Limited"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1111\/jcpt.12166","type":"journal-article","created":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T09:18:28Z","timestamp":1399540708000},"page":"424-431","source":"Crossref","is-referenced-by-count":12,"title":["Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects"],"prefix":"10.1155","volume":"39","author":[{"given":"S.","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics; Seoul National University College of Medicine and Hospital; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.-J.","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics; Seoul National University College of Medicine and Hospital; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics; Seoul National University College of Medicine and Hospital; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. S.","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics; Seoul National University College of Medicine and Hospital; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics; Seoul National University College of Medicine and Hospital; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. S.","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics; Seoul National University College of Medicine and Hospital; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-S.","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics; Seoul National University College of Medicine and Hospital; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Li","sequence":"additional","affiliation":[{"name":"Development Clinical Pharmacology Asia\/PC; Bayer HealthCare Global R&D Center; Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Development Clinical Pharmacology Asia\/PC; Bayer HealthCare Global R&D Center; Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Liu","sequence":"additional","affiliation":[{"name":"Development Clinical Pharmacology Asia\/PC; Bayer HealthCare Global R&D Center; Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Brendel","sequence":"additional","affiliation":[{"name":"Development Clinical Pharmacology Asia\/PC; Bayer HealthCare Global R&D Center; Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Blode","sequence":"additional","affiliation":[{"name":"Development Clinical Pharmacology Asia\/PC; Bayer HealthCare Global R&D Center; Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[{"name":"Development Clinical Pharmacology Asia\/PC; Bayer HealthCare Global R&D Center; Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2014,5,8]]},"reference":[{"key":"10.1111\/jcpt.12166-BIB0001|jcpt12166-cit-0001","volume-title":"Global guideline for type 2 diabetes","author":"International Diabetes Federation Clinical Guidelines Task Force","year":"2012"},{"key":"10.1111\/jcpt.12166-BIB0002|jcpt12166-cit-0002","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4158\/EP13176.CS","article-title":"American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement - executive summary","volume":"19","author":"Garber","year":"2013","journal-title":"Endocr Pract"},{"issue":"Suppl 1","key":"10.1111\/jcpt.12166-BIB0003|jcpt12166-cit-0003","doi-asserted-by":"crossref","first-page":"M44","DOI":"10.1007\/s00125-002-0936-0","article-title":"Rationale and options for combination therapy in the treatment of Type 2 diabetes","volume":"46","author":"Gaal","year":"2003","journal-title":"Diabetologia"},{"key":"10.1111\/jcpt.12166-BIB0004|jcpt12166-cit-0004","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8227(00)00163-7","article-title":"Efficacy and safety of acarbose add-on therapy in the treatment of overweight patients with Type 2 diabetes inadequately controlled with metformin: a double-blind, placebo-controlled study","volume":"50","author":"Halimi","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/jcpt.12166-BIB0005|jcpt12166-cit-0005","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/diacare.22.6.960","article-title":"A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3\u00a0years (U.K. Prospective Diabetes Study 44)","volume":"22","author":"Holman","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1111\/jcpt.12166-BIB0006|jcpt12166-cit-0006","first-page":"24","article-title":"Acarbose\/metformin combination versus metformin alone in Indonesian patients with type 2 diabetes","volume":"21","author":"Sumual","year":"2003","journal-title":"JAFES"},{"key":"10.1111\/jcpt.12166-BIB0007|jcpt12166-cit-0007","doi-asserted-by":"crossref","first-page":"928","DOI":"10.7326\/0003-4819-121-12-199412150-00004","article-title":"The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled trial","volume":"121","author":"Chiasson","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1111\/jcpt.12166-BIB0008|jcpt12166-cit-0008","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2337\/diacare.26.2.269","article-title":"Acarbose improves glycemic control in overweight type 2 diabetic patients insufficiently treated with metformin","volume":"26","author":"Phillips","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1111\/jcpt.12166-BIB0009|jcpt12166-cit-0009","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.2337\/diacare.21.12.2050","article-title":"Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes","volume":"21","author":"Rosenstock","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1111\/jcpt.12166-BIB0010|jcpt12166-cit-0010","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/diacare.23.12.1830","article-title":"Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level","volume":"23","author":"Temelkova-Kurktschiev","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1111\/jcpt.12166-BIB0011|jcpt12166-cit-0011","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jdiacomp.2011.06.004","article-title":"The beneficial effect of alpha-glucosidase inhibitor on glucose variability compared with sulfonylurea in Taiwanese type 2 diabetic patients inadequately controlled with metformin: preliminary data","volume":"25","author":"Lin","year":"2011","journal-title":"J Diabetes Complications"},{"key":"10.1111\/jcpt.12166-BIB0012|jcpt12166-cit-0012","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.clinthera.2011.10.014","article-title":"Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison","volume":"33","author":"Wang","year":"2011","journal-title":"Clin Ther"},{"key":"10.1111\/jcpt.12166-BIB0013|jcpt12166-cit-0013","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2337\/diacare.26.5.1408","article-title":"Polypharmacy and medication adherence in patients with type 2 diabetes","volume":"26","author":"Grant","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1111\/jcpt.12166-BIB0014|jcpt12166-cit-0014","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10865-007-9147-y","article-title":"The impact of medication regimen factors on adherence to chronic treatment: a review of literature","volume":"31","author":"Ingersoll","year":"2008","journal-title":"J Behav Med"},{"key":"10.1111\/jcpt.12166-BIB0015|jcpt12166-cit-0015","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjmed.2006.08.033","article-title":"Fixed-dose combinations improve medication compliance: a meta-analysis","volume":"120","author":"Bangalore","year":"2007","journal-title":"Am J Med"},{"key":"10.1111\/jcpt.12166-BIB0016|jcpt12166-cit-0016","volume-title":"Draft guidance on acarbose","author":"Food and Drug Administration","year":"2009"},{"issue":"Suppl 3","key":"10.1111\/jcpt.12166-BIB0017|jcpt12166-cit-0017","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2362.1994.tb02257.x","article-title":"Reduction of the acute bioavailability of metformin by the alpha-glucosidase inhibitor acarbose in normal man","volume":"24","author":"Scheen","year":"1994","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/jcpt.12166-BIB0018|jcpt12166-cit-0018","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.diabres.2013.08.001","article-title":"Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes","volume":"102","author":"Wang","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/jcpt.12166-BIB0019|jcpt12166-cit-0019","first-page":"186","article-title":"Effizienz und Sicherheit de Kombinationsbehandlung von Typ-2-Diabetikern mit Acarbose und Metformin","volume":"7","author":"Hanefeld","year":"1998","journal-title":"Diabetol Stoffwechsel"},{"key":"10.1111\/jcpt.12166-BIB0020|jcpt12166-cit-0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.diabres.2010.12.033","article-title":"International noninterventional study of acarbose treatment in patients with type 2 diabetes mellitus","volume":"92","author":"Li","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/jcpt.12166-BIB0021|jcpt12166-cit-0021","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40261-013-0063-3","article-title":"A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study","volume":"33","author":"Zhang","year":"2013","journal-title":"Clin Drug Investig"},{"key":"10.1111\/jcpt.12166-BIB0022|jcpt12166-cit-0022","first-page":"CD003639","article-title":"Alpha-glucosidase inhibitors for type 2 diabetes mellitus","author":"Van de Laar","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jcpt.12166-BIB0023|jcpt12166-cit-0023","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2710.2012.01339.x","article-title":"Pharmacodynamic comparison of two formulations of Acarbose 100-mg tablets","volume":"37","author":"Lee","year":"2012","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/jcpt.12166-BIB0024|jcpt12166-cit-0024","unstructured":"Bayer Plc Glucobay 50\u00a0mg Tablets. Summary of Product Characteristics http:\/\/www.medicines.org.uk\/emc\/medicine\/19972\/SPC"},{"key":"10.1111\/jcpt.12166-BIB0025|jcpt12166-cit-0025","volume-title":"Guidance for industry: statistical approaches to establishing bioequivalence","author":"Food and Drug Administration","year":"2001"},{"key":"10.1111\/jcpt.12166-BIB0026|jcpt12166-cit-0026","first-page":"679","article-title":"A prospective, parallel group, open-labeled, comparative, multi-centric, active controlled study to evaluate the safety, tolerability and benefits of fixed dose combination of acarbose and metformin versus metformin alone in type 2 diabetes","volume":"58","author":"Jayaram","year":"2010","journal-title":"J Assoc Physicians India"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12166","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12166","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12166\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T13:58:54Z","timestamp":1716731934000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12166","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,8]]}}}